Two approaches were used to assess a potential association between semaglutide and NAION: (1) an active-comparator cohort design (assessing outcomes of the new semaglutide users to the other drugs) and (2) a self-controlled case series (comparing risk during exposure vs
10.1073/pnas.0914076107 98 ValerioA.BassoD.BrigatoL.CeolottoG.BaldoG.TiengoA.et al (1999)
Not seeing results If you are on both HRT and a GLP-1 medication but not seeing expected results, several factors may be at play: Check hormone levels
Results of this integrated analysis suggest that the triple combination of GLP-1RA, SGLT2i, and finerenone provides stronger cardiorenal protective benefits than either conventional therapy or each alone
Supplement support GLP-1 therapy can create specific nutritional gaps that targeted supplementation addresses
Therefore, gut dysbiosis in depressed individuals can exacerbate metabolic dysfunction and IR, linking gut health to diabetes and mental health